Please login to the form below

Not currently logged in
Email:
Password:

Daniel O'Day

This page shows the latest Daniel O'Day news and features for those working in and with pharma, biotech and healthcare.

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

Gilead’s COVID-19 drug Veklury brought in almost $2bn in Q4

treated with the drug, according to Gilead's chief executive officer Daniel O’Day.

Latest news

More from news
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    A number of clinical trials evaluating remdesivir’s efficacy in COVID-19 are currently underway in China and the US, with Gilead CEO Daniel O’Day commenting that “initial data” is ... have activity for,” added O’Day.

  • 20 for 2020 – Five pharma leaders to watch in 2020 20 for 2020 – Five pharma leaders to watch in 2020

    The pipeline-building deal is the largest under new Gilead chief executive Daniel O’Day, who took the helm of Gilead in March 2019, and includes a massive $3.95bn upfront,

  • The rise of real-world evidence The rise of real-world evidence

    Having been stung by drugs that shine in RCTs but under deliver in day-to-day practice, these stakeholders want to know what effect therapies will have on people in the ... The takeover was driven by a belief that “regulatory-grade real-world evidence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics